BioCryst grants inducement equity awards to 12 new hires under Nasdaq rule 5635(c)(4)

Reuters04-03
BioCryst grants inducement equity awards to 12 new hires under Nasdaq rule 5635(c)(4)
  • BioCryst compensation committee granted inducement equity awards to 12 newly hired employees effective April 1, 2026.
  • Awards included stock options covering 33,950 shares at an exercise price of $9.38 per share.
  • Grants also included restricted stock units covering 123,350 shares.
  • Options and RSUs vest in four equal annual installments starting one year from grant date.
  • Stock options carry a 10-year term.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCryst Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604030700PRIMZONEFULLFEED9683582) on April 03, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment